Abbott Laboratories (ABT) Land & Improvements (2009 - 2021)
Abbott Laboratories (ABT) reported Land & Improvements of $525.0 million for Q4 2021, down 2.42% on a YoY basis from $538.0 million in Q4 2020, and down 2.42% sequentially from $538.0 million in Q4 2020.
Abbott Laboratories (ABT) Land & Improvements (2009 - 2021) Analysis & Trends
Abbott Laboratories (ABT) has 12 years of Land & Improvements data on file, last reported at $525.0 million in Q4 2021.
- For the quarter ending Q4 2021, Land & Improvements fell 2.42% year-over-year to $525.0 million; the trailing twelve-month figure through Dec 2021 stood at $525.0 million (down 2.42% YoY), and the FY2021 full-year result was $525.0 million, down 2.42% from the prior year.
- Land & Improvements fell to $525.0 million in Q4 2021, from $538.0 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $538.0 million in Q4 2020 to a low of $501.0 million in Q4 2018.
- A 5-year average of $521.8 million and a median of $525.0 million in 2021 frame the typical range for Land & Improvements.
- Across the five-year window, Land & Improvements climbed 28.92% in 2017 and decreased 4.75% in 2018, its largest moves.
- Tracing ABT's Land & Improvements over 5 years: stood at $526.0 million in 2017, then decreased by 4.75% to $501.0 million in 2018, then climbed by 3.59% to $519.0 million in 2019, then increased by 3.66% to $538.0 million in 2020, then decreased by 2.42% to $525.0 million in 2021.
- Business Quant data shows ABT's Land & Improvements at $525.0 million in Q4 2021, $538.0 million in Q4 2020, and $519.0 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 112.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 525.00 Mn |
| Dec 31, 2020 | 538.00 Mn |
| Dec 31, 2019 | 519.00 Mn |
| Dec 31, 2018 | 501.00 Mn |
| Dec 31, 2017 | 526.00 Mn |
| Dec 31, 2016 | 408.00 Mn |
| Dec 31, 2015 | 432.00 Mn |
| Dec 31, 2013 | 502.00 Mn |
| Dec 31, 2012 | 605.00 Mn |
| Dec 31, 2011 | 633.92 Mn |
| Dec 31, 2010 | 648.99 Mn |
| Dec 31, 2009 | 546.20 Mn |